Blog
Two women have filed a GranuFlo lawsuit in the U.S. District Court in Oakland, California. The claim was filed on March 28, 2013 by plaintiffs Deborah Lower and Constance Morgan. The ladies allege that the acid concentrate caused their mother’s death.
GranuFlo is an dry acid product that is widely used in many dialysis centers all over the United States. This dialysis ingredient, which was produced by Fresenius Medical Care, assists in neutralizing the acidity in the blood of dialysis patients. It was certified by the U.S. Food and Drug Administration (FDA) in 2003. It grew in popularity, reaching a point where it became one of the most widely used acid concentrates in the United States.
Following its market release date, however, several research studies linked GranuFlo to heart problems. In fact, a post-marketing study conducted by Fresenius itself also indicated that GranuFlo may increase the risk of developing heart-related adverse effects that could eventually result in patient deaths. According to the study, dialysis patients administered with the product are six to eight times more susceptible to develop such complications in comparison to those who were given alternative treatments.
After uncovering the serious risks of GranuFlo, Fresenius released a warning notice to all its company-owned dialysis facilities. Reports indicate, however, that the company neglected to warn other dialysis centers using the acid concentrate. This purportedly led to countless injuries and deaths.
According to medical experts, components of the dialysate GranuFlo transforms into bicarbonate when it enters the bloodstream. These experts explain that elevated levels of bicarbonate in the blood of dialysis patients can result in alkalosis. Alkalosis is a serious condition in which the hydrogen ion concentration of the arterial blood plasma, also known as alkalemia, is considerably reduced. This may ultimately lead to a heart attack and sudden death.
The woman at the center of the above mentioned case, Beaulahfay Riddie, reportedly died while going through dialysis treatment. Her doctors indicated that cause of death was cardiac arrest. Before her unfortunate passing, the case claimed that she developed metabolic alkalosis, which was allegedly caused by GranuFlo.
injurylawyer-news.com/2013/04/naturalyte-and-granuflo-lawsuit-alleges-wrongful-death/
Dialysis treatment is often prescribed to help men and women who have end-stage renal disease eliminate the wastes in the blood, health care experts say, but it also has several complications associated to long-term use. Conservative treatment without dialysis is one of the possible options for people with irreversible kidney damage, according to the Renal Resource Centre (RRC). If the patient refuses to have dialysis or a new kidney, he or she might still be able to live the same as those who are receiving dialysis treatment. The recent consolidation of GranuFlo lawsuits in Massachusetts state court has even added to the fears of some elderly individuals to undergo dialysis treatment.
Knowing that one has end-stage renal disease (the kidney has already incurred irreversible damages) may seem overwhelming but it is important to choose the treatment before the symptoms start to show. Family members are often included in the decision because they need to assist patients in their choices. For men and women over the age of 60 who are frail, dialysis treatment may not be effective because of the comorbidities of this type of treatment. An average of life expectancy of four years is possible for older adults with ages over 75 years old who are under dialysis treatment, according to the National Health Services in the United Kingdom.
Conservative treatment for end-stage kidney disease may focus more on treating the symptoms of the disease. Rather than preventing the disease, it allows the disease to run its natural course but will help the patient be more comfortable by treating the pressing symptoms. Drug and diet management are the combination that is used to alleviate the symptoms of renal failure. Most of the symptoms experienced by those who are undergoing conservative treatment are also experienced by those who are under dialysis treatment. The symptoms that are being managed are lack of energy, loss of appetite, fluid retention and ankle swelling, bruising, pins and needles in the hands or feet, itch, nausea and shortness of breath
Kidney functions are still being preserved through this type of medical management but it does not replace the functions of the kidney. However, patients and family members need to be aware that this course of decision might eventually lead to death. This possibility is often discussed by health care providers to patients before they undergo the treatment. There are some family members who have filed a GranuFlo and NaturaLyte lawsuit after a family member died of heart attack related to their dialysis treatment.
URL References:
renalresource.com/pdf/IntroCCACKD.pdf
ncbi.nlm.nih.gov/pubmed/18029376
cjasn.asnjournals.org/content/4/10/1611.abstract